| Business Summary | | Trimedyne,
Inc.
is
engaged
in
the
development,
manufacturing
and
marketing
of
Holmium
cold
pulsed
Lasers,
Nd:YAG
thermal
continuous
wave
lasers
and
proprietary,
disposable
fiber-optic
laser
delivery
devices
for
use
in
orthopedics,
urology,
ear,
nose
and
throat
(ENT)
surgery,
gynecology,
general
surgery
and
other
medical
specialties.
A
90%-owned
subsidiary
of
the
Company,
Cardiodyne,
Inc.,
is
engaged
in
the
development
and
testing
of
a
new,
automated
system
using
the
Company's
80-watt
Holmium
laser
to
treat
severe
angina
(chest
pain
due
to
blockages
in
one
or
more
of
the
coronary
arteries). | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Trimedyne
is
engaged
in
the
research
and
development,
manufacture
and
sale
of
lasers
and
disposable
laser
devices
in
the
medical
field.
For
the
nine
months
ended
6/30/01,
net
sales
rose
6%
to
$5.4
million.
Net
loss
rose
83%
to
$4.1
million.
Sales
reflect
higher
rental
revenues.
Higher
loss
reflects
lower
gross
margins,
expansion
of
the
sales
and
marketing
efforts,
higher
personnel,
rent,
utility
and
insurance
costs
and
a
$953
thousand
impairment
on
marketable
securities. | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Marvin Loeb, 74 Chairman,
Pres, CEO | $228K | Stephen Byrne VP-Operations | -- | Brian Kenney VP,
Global Sales and Marketing | -- | Dollar amounts are as of 30-Sep-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|